• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Silent myocardial infarctions more common than previously assumed

bys25qthea
July 10, 2014
in Cardiology, Chronic Disease
Reading Time: 3 mins read
Silent myocardial infarctions more common than previously assumed
Share on FacebookShare on Twitter

Image: PD

1. The prevalence of silent myocardial infarction (MI) in patients referred for coronary artery disease (CAD) evaluation is higher than previously thought, approaching one-quarter of all patients in this study.  

2. Silent MI is 50% more common among patients with diabetes mellitus.  

Evidence Rating Level: 2 (Good)  

Study Rundown: Silent myocardial infarctions (MIs) lack unequivocal objective signs of myocardial infarction and have minimal, atypical, or no symptoms at all. Most such MIs are diagnosed with screening ECGs, though previous studies have demonstrated the low sensitivity of this method compared to myocardial perfusion single photon emission computed tomography (MPS). This study confirms that MPS improves the diagnostic capability of ECGs, as many patients with substantial infarctions lacked characteristic Q waves on ECG. It also suggests that silent MIs are more common than previously recognized, especially among diabetics. Nearly one quarter of enrolled patients had experienced a silent MI that had gone unrecognized. However, the study does not assess the prognosis of silent MIs; as such, the authors’ argument in favor of increased imaging modalities for detection and increased secondary prevention therapies cannot be backed by claims of cost-effectiveness. Future studies are required to determine optimal screening and prevention for individuals determined to be at risk for silent MIs.   

Click to read the study in The American Journal of Medicine

RELATED REPORTS

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

Relevant Reading: Silent Myocardial Ischemia in Patients With Diabetes Mellitus

In-Depth [prospective cohort study]: This study analyzes silent myocardial infarction (MI) among two cohorts of patients without a prior history of MI who were referred for stress testing. Study participants underwent stress testing (exercise, pharmacological, or combined) and myocardial perfusion single photon emission computed tomography (MPS). Silent MI was defined by myocardial scar greater than or equal to 5% of the left ventricle, based on perfusion images. In the derivation cohort of 1621 patients, prevalence of silent MI was 23.3% – 28.5% in diabetics and 21.5% in nondiabetics. Median infarct size was 10%. These findings were confirmed in a validation cohort of 338 patients, with silent MI prevalence of 26.3%. In both cohorts, diabetes was a significant independent predictor of silent MI, with silent MI prevalence 50% higher in diabetic patients. Among diabetics with silent MI, median left ventricular ejection fraction was 47%, significantly lower than among nondiabetics. Those with silent MI were more likely to be male, have a positive family history of CAD, and had a higher number of Q waves on ECG. However, classical ECG criteria missed 2 of 3 silent MIs.

By Elizabeth Kersten and Andrew Bishara

More from this author: Meta-analysis updates recommendations for C-sections, Early childhood growth improves adult health outcomes in developing countries, Shorter telomere length linked with increased risk of common cold, Breastfeeding associated with lower rates of hypertension, Health information technology improves obesity treatment access and screening, Undervaccination becoming more common, associated with increased admission rates

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: Coronary artery diseaseheart attackmyocardial infarction
Previous Post

Increased inflammatory markers found in nonsurviving pediatric burn patients

Next Post

Contraband tobacco leads to reduced smoking cessation

RelatedReports

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

January 12, 2026
Lariat device for left atrial appendage exclusion associated with adverse events
Cardiology

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

January 13, 2026
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

October 30, 2025
β-blockers linked to improved survival in preserved ejection fraction heart failure
Cardiology

Multidomain rehabilitation after myocardial infarction improves outcomes in older adults

October 15, 2025
Next Post
Contraband tobacco leads to reduced smoking cessation

Contraband tobacco leads to reduced smoking cessation

USPSTF recommends chemoprevention for women at high risk for breast cancer

USPSTF recommends chemoprevention for women at high risk for breast cancer

Light drinking during pregnancy may be safe

Light drinking during pregnancy may be safe

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic exposure to particulate matter is associated with increased cardiovascular risk
  • Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans
  • FDA-cleared AI devices rarely have patient outcome data
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.